查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475885

動物骨科植入物市場：依地區（北美、歐洲、亞太地區、拉丁美洲、中東非洲）：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031

Orthopedic Veterinary Implants Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 132 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究發佈了一份對全球動物骨科植入物市場進行深入分析的報告。 該報告提供了關鍵市場動態的全面見解，包括成長動力、課題、新興趨勢和關鍵市場發展。 該研究涵蓋2024年至2031年期間，為利害關係人做出明智決策和製定策略計畫提供有價值的資訊。

全球動物骨科植入物市場預計將從 2024 年的 29 億美元增至 2031 年的 53 億美元，預測期內複合年增長率為 9%。

關鍵見解

  • 獸用骨科植入物市場規模（2024 年預估）：29 億美元
  • 市場預測值（2031 年預測）：53 億美元
  • 全球市場成長率（2024-2031 年複合年增長率）：9%

動物骨科植入物市場-調查範圍：

寵物擁有量的增加和對先進獸醫治療的投資意願不斷增強是動物骨科植入物市場的主要驅動力。 隨著寵物主人為他們的動物尋求優質的醫療護理，對用於治療骨折、關節疾病和退化性疾病等疾病的骨科植入物的需求不斷增長。 植入物設計和材料的技術進步正在帶來更有效的治療並推動市場發展。

此外，獸醫行業對提供專業護理的關注增加了對熟練骨科醫生和先進設備的需求，從而推動了新產品和治療方法的開發。 此外，提供骨科服務的獸醫院和診所數量的增加也促進了市場的擴張。

推動市場成長的因素：

有幾個因素正在推動動物骨科植入物市場的成長。 由於寵物數量的增加以及寵物的人性化，越來越多的寵物主人正在尋求專業治療。 這一趨勢得到了可支配收入增加的支持，這使得寵物主人能夠負擔得起更複雜和更昂貴的手術。

技術進步也發揮著重要作用，鈦和不銹鋼等植入材料的創新創造了更耐用和生物相容性的產品。 微創手術技術的採用可以縮短寵物的恢復時間並降低風險。 此外，獸醫和寵物主人已經意識到骨科植入物的好處，推動了市場的成長。

市場限制因素：

儘管成長，動物骨科植入物市場仍面臨課題。 矯形手術和植入物的高昂成本讓一些所有者望而卻步，並限制了他們進入市場。 在發展中國家尤其如此，這些國家獲得獸醫保健的機會很差且收入水準較低。 這些複雜的手術需要專門的培訓，而熟練的骨科獸醫的數量有限也阻礙了這項培訓。 有關產品審批和動物福利的監管障礙也可能減緩市場擴張。 此外，原物料價格的波動會影響植入物的製造成本並影響市場動態。

市場機會：

動物骨科植入物市場存在多種成長和擴張機會。 公司可以專注於開發具有成本效益的植入物，以服務更廣泛的客戶，特別是在新興市場。 此外，寵物保險的日益普及將使寵物主人能夠負擔昂貴的手術，從而促進市場成長。 獸醫學校、研究機構和植入物製造商之間的合作研究促使了創新產品和技術的開發，從而推動了市場成長。 人們對動物福利意識的不斷提高以及對優質獸醫護理的需求預計也將為市場參與者創造新的機會。

本報告涵蓋的主要問題

  • 動物骨科植入物市場的預期複合年增長率是多少？
  • 推動動物骨科植入物市場成長的關鍵因素是什麼？
  • 哪個地區在動物骨科植入物市場中佔有最大的市佔率？
  • 全球動物骨科植入物市場的主要參與者有哪些？
  • 主要參與者採取哪些策略來維持動物骨科植入物市場的成長？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第三章市場動態

  • 宏觀經濟因素
  • 促進因素
    • 供給面因素
    • 需求方驅動因素
  • 抑制因素
  • 機會
  • 趨勢

第四章主要內容

  • 狗的關節炎
  • 美國的日常護理
  • 寵物護理

第五章全球動物骨科植體市場分析（金額）

  • 過去的市場（金額）分析，2019-2023 年
  • 2024-2031 年當前及未來市場（金額）預測

第 6 章全球動物骨科植體市場分析、產品類型

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023 年
  • 2024-2031 年當前與未來市場規模（金額）分析與預測
    • 全膝關節置換術 (TKR)
    • 全髖關節置換術 (THR)
    • 創傷固定
    • 脛骨結節推進 (TTA) 植體
    • 脛骨平台整平截骨術 (TPLO) 植入物
    • 高級鎖定板系統 (ALPS)
    • 全手肘關節置換術 (TER)
  • 依產品類型進行市場吸引力分析

第 7 章最終使用者的全球動物骨科植入物市場分析

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023 年
  • 2024-2031 年當前與未來市場規模（金額）分析與預測
    • 動物醫院
    • 獸醫診所
  • 最終用戶的市場吸引力分析

第 8 章依地區劃分的全球動物骨科植入物市場分析

  • 簡介
  • 過去的市場規模（金額）分析，2019-2023 年
  • 2024-2031 年目前市場規模（金額）分析與預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 依地區劃分的市場吸引力分析

第九章北美動物骨科植入物市場分析

第10章拉丁美洲動物骨科植體市場分析

第11章歐洲動物骨科植體市場分析

第十二章亞太動物骨科植體市場分析

第十三章中東與非洲動物骨科植體市場分析

第14章競爭分析

  • 競爭對手儀表板
  • 衝突詳情
    • Vet Implants
    • scil animal care company GmbH
    • KYON Pharma, Inc.
    • Everost Inc.
    • BioMedtrix, LLC
    • Integra LifeSciences
    • RITA LEIBINGER MEDICAL GmbH &Co. KG
    • B. Braun Melsungen AG
    • DePuy Synthes（Sub. Johnson &Johnson Services, Inc.）
    • Intrauma SpA
    • Surgical Holdings
    • Ortho Max Manufacturing Company Pvt. Ltd. Novartis AG

第 15 章先決條件與使用的縮寫

第十六章研究方法

簡介目錄
Product Code: PMRREP22939

Persistence Market Research has released an in-depth analysis examining the global Orthopedic Veterinary Implants Market. This report provides comprehensive insights into key market dynamics, including growth drivers, challenges, emerging trends, and significant developments. The study covers the period from 2024 through 2031, presenting valuable information for stakeholders to make informed decisions and develop strategic plans.

The global orthopedic veterinary implants market is anticipated to grow at a CAGR of 9% during the forecast period, with the market expected to reach a value of USD 5.3 billion by 2031, up from an estimated USD 2.9 billion in 2024.

Key Insights:

  • Orthopedic Veterinary Implants Market Size (2024 Estimate): USD 2.9 Billion
  • Projected Market Value (2031 Forecast): USD 5.3 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 9%

Orthopedic Veterinary Implants Market - Report Scope:

The rising pet ownership and the increasing willingness of pet owners to invest in advanced veterinary care are key drivers of the orthopedic veterinary implants market. As pet owners seek high-quality medical treatments for their animals, there is a growing demand for orthopedic implants to treat conditions like fractures, joint disorders, and degenerative diseases. Technological advancements in implant design and materials have led to more effective treatments, which is boosting the market.

Additionally, the veterinary industry's focus on providing specialized care has created a greater need for skilled orthopedic surgeons and advanced equipment, fostering the development of new products and treatment methods. Furthermore, the increase in veterinary clinics and hospitals offering orthopedic services contributes to the market's expansion.

Market Growth Drivers:

Several factors are driving the growth of the orthopedic veterinary implants market. The growing pet population and the humanization of pets are leading more pet owners to seek specialized treatments. This trend is supported by higher disposable incomes, allowing pet owners to afford more complex and expensive procedures.

Technological advancements have also played a crucial role, with innovations in implant materials like titanium and stainless steel, resulting in more durable and biocompatible products. The adoption of minimally invasive surgical techniques is gaining traction, leading to faster recovery times and reduced risks for pets. Moreover, veterinarians and pet owners are becoming more aware of the benefits of orthopedic implants, driving market growth.

Market Restraints:

Despite its growth, the orthopedic veterinary implants market faces challenges. The high cost of orthopedic procedures and implants can be prohibitive for some pet owners, limiting market reach. This is especially true in developing countries where veterinary care is less accessible, and income levels are lower. The limited availability of skilled orthopedic veterinarians is another restraint, as specialized training is required for these complex procedures. Regulatory hurdles related to product approvals and animal welfare concerns can also slow down the market's expansion. Additionally, fluctuations in raw material prices can affect the cost of manufacturing implants, impacting market dynamics.

Market Opportunities:

The orthopedic veterinary implants market offers several opportunities for growth and expansion. Companies can focus on developing cost-effective implants to cater to a broader range of customers, especially in emerging markets. The increasing adoption of pet insurance can also drive market growth by making expensive procedures more affordable for pet owners. Collaborations between veterinary schools, research institutions, and implant manufacturers can lead to the development of innovative products and techniques, fostering market growth. The rising awareness of animal welfare and the demand for high-quality veterinary care are also expected to create new opportunities for market players.

Key Questions Addressed in the Report:

  • What is the Expected Value CAGR of the Orthopedic Veterinary Implants Market?
  • What are the Key Factors Driving the Growth of the Orthopedic Veterinary Implants Market?
  • Which Region Holds the Largest Market Share in the Orthopedic Veterinary Implants Market?
  • Who are the Key Players in the Global Orthopedic Veterinary Implants Market?
  • What Strategies are Adopted by Leading Companies to Sustain Growth in the Orthopedic Veterinary Implants Market?

Competitive Landscape and Business Strategies:

Leading companies in the orthopedic veterinary implants market include DePuy Synthes, BioMedtrix, VetStem Biopharma, and Veterinary Orthopedic Implants, among others. These companies focus on product innovation, quality, and strategic partnerships to maintain their competitive edge.

Strategies such as expanding distribution networks, investing in research and development, and collaborating with veterinary hospitals are commonly employed to drive growth. Companies also focus on providing comprehensive training and support to veterinary professionals to ensure successful implant outcomes.

Key Companies Profiled:

  • Vet Implants
  • scil animal care company GmbH
  • KYON Pharma, Inc.
  • Everost Inc.
  • BioMedtrix, LLC
  • Integra LifeSciences
  • RITA LEIBINGER MEDICAL GmbH & Co. KG
  • B. Braun Melsungen AG

Orthopedic Veterinary Implants Market Segmentation:

Orthopedic Veterinary Implants Market by By Product type

  • Total Knee Replacement
  • Total Hip Replacement
  • Trauma Fixations
  • Tibial Tuberosity Advancement Implants
  • Tibial Plateau Leveling Osteotomy Implants
  • Advanced Locking Plate System
  • Total Elbow Replacement

Orthopedic Veterinary Implants Market By End User

  • Veterinary Hospitals
  • Veterinary Clinics

Orthopedic Veterinary Implants Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Dynamics

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
    • 3.2.1. Supply Side Drivers
    • 3.2.2. Demand Side Drivers
  • 3.3. Restraints
  • 3.4. Opportunities
  • 3.5. Trends

4. Key Inclusion

  • 4.1. Arthritis in Dogs
  • 4.2. Routine Care in U.S.
  • 4.3. Pet Ownership

5. Global Orthopedic Veterinary Implants Market Value Analysis 2019-2023 and Forecast, 2024-2031

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
    • 6.3.1. Total Knee Replacement (TKR)
    • 6.3.2. Total Hip Replacement (THR)
    • 6.3.3. Trauma Fixations
    • 6.3.4. Tibial Tuberosity Advancement (TTA) Implants
    • 6.3.5. Tibial Plateau Leveling Osteotomy (TPLO) Implants
    • 6.3.6. Advanced Locking Plate System (ALPS)
    • 6.3.7. Total Elbow Replacement (TER)
  • 6.4. Market Attractiveness Analysis By Product Type

7. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
  • 7.4. Market Attractiveness Analysis By End User

8. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia-Pacific
    • 8.3.5. Middle East & Africa
  • 8.4. Market Attractiveness Analysis By Region

9. North America Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 9.3.1. By Country
      • 9.3.1.1. U.S.
      • 9.3.1.2. Canada
    • 9.3.2. By Product Type
    • 9.3.3. By End User
  • 9.4. Market Attractiveness Analysis
  • 9.5. Drivers & Restraints: Impact Analysis

10. Latin America Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 10.3.1. By Country
      • 10.3.1.1. Brazil
      • 10.3.1.2. Mexico
      • 10.3.1.3. Rest of Latin America
    • 10.3.2. By Product Type
    • 10.3.3. By End User
  • 10.4. Market Attractiveness Analysis
  • 10.5. Drivers & Restraints: Impact Analysis

11. Europe Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 11.3.1. By Country
      • 11.3.1.1. Germany
      • 11.3.1.2. U.K.
      • 11.3.1.3. France
      • 11.3.1.4. Italy
      • 11.3.1.5. Spain
      • 11.3.1.6. Poland
      • 11.3.1.7. Russia
      • 11.3.1.8. Rest of Europe
    • 11.3.2. By Product Type
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
  • 11.5. Drivers & Restraints: Impact Analysis

12. Asia-Pacific Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. China
      • 12.3.1.2. India
      • 12.3.1.3. Japan
      • 12.3.1.4. Australia & New Zealand
      • 12.3.1.5. Rest of Asia-Pacific
    • 12.3.2. By Product Type
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers & Restraints: Impact Analysis

13. Middle East and Africa Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. GCC Countries
      • 13.3.1.2. South Africa
      • 13.3.1.3. Rest of MEA
    • 13.3.2. By Product Type
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers & Restraints: Impact Analysis

14. Competition Analysis

  • 14.1. Competition Dashboard
  • 14.2. Competition Deep Dive
    • 14.2.1. Vet Implants
      • 14.2.1.1. Company Overview
      • 14.2.1.2. Segment Overview
      • 14.2.1.3. Product Offerings
      • 14.2.1.4. Financial Analysis
      • 14.2.1.5. Key Developments
      • 14.2.1.6. Strategy Overview
    • 14.2.2. scil animal care company GmbH
      • 14.2.2.1. Company Overview
      • 14.2.2.2. Segment Overview
      • 14.2.2.3. Product Offerings
      • 14.2.2.4. Financial Analysis
      • 14.2.2.5. Key Developments
      • 14.2.2.6. Strategy Overview
    • 14.2.3. KYON Pharma, Inc.
      • 14.2.3.1. Company Overview
      • 14.2.3.2. Segment Overview
      • 14.2.3.3. Product Offerings
      • 14.2.3.4. Financial Analysis
      • 14.2.3.5. Key Developments
      • 14.2.3.6. Strategy Overview
    • 14.2.4. Everost Inc.
      • 14.2.4.1. Company Overview
      • 14.2.4.2. Segment Overview
      • 14.2.4.3. Product Offerings
      • 14.2.4.4. Financial Analysis
      • 14.2.4.5. Key Developments
      • 14.2.4.6. Strategy Overview
    • 14.2.5. BioMedtrix, LLC
      • 14.2.5.1. Company Overview
      • 14.2.5.2. Segment Overview
      • 14.2.5.3. Product Offerings
      • 14.2.5.4. Financial Analysis
      • 14.2.5.5. Key Developments
      • 14.2.5.6. Strategy Overview
    • 14.2.6. Integra LifeSciences
      • 14.2.6.1. Company Overview
      • 14.2.6.2. Segment Overview
      • 14.2.6.3. Product Offerings
      • 14.2.6.4. Financial Analysis
      • 14.2.6.5. Key Developments
      • 14.2.6.6. Strategy Overview
    • 14.2.7. RITA LEIBINGER MEDICAL GmbH & Co. KG
      • 14.2.7.1. Company Overview
      • 14.2.7.2. Segment Overview
      • 14.2.7.3. Product Offerings
      • 14.2.7.4. Financial Analysis
      • 14.2.7.5. Key Developments
      • 14.2.7.6. Strategy Overview
    • 14.2.8. B. Braun Melsungen AG
      • 14.2.8.1. Company Overview
      • 14.2.8.2. Segment Overview
      • 14.2.8.3. Product Offerings
      • 14.2.8.4. Financial Analysis
      • 14.2.8.5. Key Developments
      • 14.2.8.6. Strategy Overview
    • 14.2.9. DePuy Synthes (Sub. Johnson & Johnson Services, Inc.)
      • 14.2.9.1. Company Overview
      • 14.2.9.2. Segment Overview
      • 14.2.9.3. Product Offerings
      • 14.2.9.4. Financial Analysis
      • 14.2.9.5. Key Developments
      • 14.2.9.6. Strategy Overview
    • 14.2.10. Intrauma S.p.A.
      • 14.2.10.1. Company Overview
      • 14.2.10.2. Segment Overview
      • 14.2.10.3. Product Offerings
      • 14.2.10.4. Financial Analysis
      • 14.2.10.5. Key Developments
      • 14.2.10.6. Strategy Overview
    • 14.2.11. Surgical Holdings
      • 14.2.11.1. Company Overview
      • 14.2.11.2. Segment Overview
      • 14.2.11.3. Product Offerings
      • 14.2.11.4. Financial Analysis
      • 14.2.11.5. Key Developments
      • 14.2.11.6. Strategy Overview
    • 14.2.12. Ortho Max Manufacturing Company Pvt. Ltd. Novartis AG
      • 14.2.12.1. Company Overview
      • 14.2.12.2. Segment Overview
      • 14.2.12.3. Product Offerings
      • 14.2.12.4. Financial Analysis
      • 14.2.12.5. Key Developments
      • 14.2.12.6. Strategy Overview

15. Assumptions and Acronyms Used

16. Research Methodology